BioSyent Inc. (CVE:RX) Announces $0.05 Quarterly Dividend

Key Points

• BioSyent Inc. has declared a quarterly dividend of $0.05 per share, which will be paid to stockholders of record on August 29th.
• The company's current dividend yield stands at 1.7%, reflecting its commitment to returning value to shareholders.
• BioSyent's stock opened at C$11.59, with a market capitalization of C$132.56 million and a 12-month price range between C$9.20 and C$12.13.

BioSyent Inc. (CVE:RX - Get Free Report) announced a quarterly dividend on Thursday, August 21st, RTT News reports. Shareholders of record on Friday, August 29th will be given a dividend of 0.05 per share on Monday, September 15th. This represents a c) annualized dividend and a yield of 1.7%.

BioSyent Stock Up 0.4%

Shares of RX stock traded up C$0.05 on Wednesday, hitting C$12.10. The stock had a trading volume of 5,950 shares, compared to its average volume of 4,137. The firm has a market capitalization of C$138.39 million, a price-to-earnings ratio of 19.64 and a beta of 0.93. The stock's 50 day moving average is C$11.60 and its 200-day moving average is C$11.25. The company has a debt-to-equity ratio of 2.90, a quick ratio of 6.91 and a current ratio of 3.92. BioSyent has a 52-week low of C$9.20 and a 52-week high of C$12.40.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.